AbCellera Biologics Funding: $195M Raised, Series B (2020)

AbCellera Biologics is based in Vancouver, Canada. It has raised $195M in total funding. Latest round: Series B.

AbCellera Biologics funding overview

AbCellera Biologics is based in Vancouver, Canada. AbCellera Biologics has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2020. The round record for AbCellera Biologics runs through 2020; nothing later has been disclosed. Investors on record include Founders Fund, UpHonest Capital, Peter Thiel, Accel, Advancit Capital, Antler and 8 others. 14 distinct backers are named across the disclosed rounds.

AbCellera Biologics at a glance

Total raised
$195M
Latest round
Series B
Latest round date
May 2020
Headquarters
Vancouver, Canada
Notable investors
Founders Fund, UpHonest Capital, Peter Thiel, Accel, Advancit Capital, Antler, Dreamers VC, Equity Alliance

Frequently asked about AbCellera Biologics funding

How much has AbCellera Biologics raised?
AbCellera Biologics has raised $195M in total disclosed funding across the rounds on record.
Who has invested in AbCellera Biologics?
Founders Fund, UpHonest Capital, Peter Thiel, Accel, Advancit Capital, Antler are named among the investors backing AbCellera Biologics.
What was the latest AbCellera Biologics funding round?
The most recent disclosed round is a Series B, announced in May 2020.
Where is AbCellera Biologics based?
AbCellera Biologics is based in Vancouver, Canada.
When did AbCellera Biologics last raise?
The last disclosed AbCellera Biologics round closed in May 2020 at Series B.

We update the AbCellera Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Vancouver and their backers are listed below.

Companies related to AbCellera Biologics (35)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades